FRLAX | VGSLX | FRLAX / VGSLX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 23 years | - |
Gain YTD | 11.780 | 13.465 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 296M | 70.5B | 0% |
Annual Yield % from dividends | 2.19 | 3.99 | 55% |
Returns for 1 year | 19.83 | 26.90 | 74% |
Returns for 3 years | -7.09 | 3.61 | -196% |
Returns for 5 years | -7.83 | 26.75 | -29% |
Returns for 10 years | 23.40 | 86.20 | 27% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYAVX | 74.05 | 0.26 | +0.35% |
Rydex S&P MidCap 400 Pure Value H | |||
JGYAX | 12.47 | -0.01 | -0.08% |
JHancock Global Shareholder Yield A | |||
FBIOX | 21.47 | -0.08 | -0.37% |
Fidelity Select Biotechnology | |||
GQFIX | 11.95 | -0.05 | -0.42% |
GQG Partners Global Quality Div Inc Ins | |||
FCIVX | 18.79 | -0.12 | -0.63% |
Frontier MFG Core Infrastructure Service |